Lineage Cell (Israel) Probability of Future Stock Price Finishing Over 190.0
BTX Stock | ILS 199.60 5.60 2.89% |
Lineage |
Lineage Cell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lineage Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lineage Cell Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Lineage Cell had very high historical volatility over the last 90 days | |
The company reported the revenue of 4.99 M. Net Loss for the year was (45.99 M) with profit before overhead, payroll, taxes, and interest of 4.69 M. | |
Lineage Cell Therapeutics has accumulated about 27.1 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. |
Lineage Cell Technical Analysis
Lineage Cell's future price can be derived by breaking down and analyzing its technical indicators over time. Lineage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lineage Cell Therapeutics. In general, you should focus on analyzing Lineage Stock price patterns and their correlations with different microeconomic environments and drivers.
Lineage Cell Predictive Forecast Models
Lineage Cell's time-series forecasting models is one of many Lineage Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lineage Cell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lineage Cell Therapeutics
Checking the ongoing alerts about Lineage Cell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lineage Cell Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Lineage Cell had very high historical volatility over the last 90 days | |
The company reported the revenue of 4.99 M. Net Loss for the year was (45.99 M) with profit before overhead, payroll, taxes, and interest of 4.69 M. | |
Lineage Cell Therapeutics has accumulated about 27.1 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. |
Additional Information and Resources on Investing in Lineage Stock
When determining whether Lineage Cell Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lineage Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lineage Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lineage Cell Therapeutics Stock:Check out Lineage Cell Backtesting, Lineage Cell Valuation, Lineage Cell Correlation, Lineage Cell Hype Analysis, Lineage Cell Volatility, Lineage Cell History as well as Lineage Cell Performance. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.